| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/08/2000 | EP0983095A2 Peptide-coated implants and methods for producing same |
| 03/08/2000 | EP0800527B1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 03/08/2000 | EP0571390B1 The delay, prevention and/or reversal of cell senescence |
| 03/08/2000 | CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action |
| 03/07/2000 | US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists |
| 03/07/2000 | US6034237 3-imino-cephalosporins |
| 03/07/2000 | US6034216 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/07/2000 | US6034215 3-amino-2-oxo-1-piperidnercetic derivatives as enzyme inhibitors |
| 03/07/2000 | US6034135 Delivering anionic macromolecule to cell |
| 03/07/2000 | US6034104 Anticoagulant agents |
| 03/07/2000 | US6034097 Isoquinolines useful as analgesics |
| 03/07/2000 | US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/07/2000 | US6034067 Serine protease inhibitors |
| 03/07/2000 | US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases |
| 03/07/2000 | US6034065 Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 |
| 03/07/2000 | US6034058 Administering polypeptide |
| 03/07/2000 | US6034055 Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars |
| 03/07/2000 | US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
| 03/07/2000 | CA2109646C Para-nitroanilide peptides |
| 03/02/2000 | WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 03/02/2000 | WO2000011022A1 Anti-cancer compounds and methods related thereto |
| 03/02/2000 | WO2000011021A1 5-membered ring compounds |
| 03/02/2000 | WO2000011020A1 Deoxyhypusine reagent and peptides |
| 03/02/2000 | WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 03/02/2000 | WO1999064043A9 Muscarinic receptor antagonists |
| 03/02/2000 | CA2306456A1 Deoxyhypusine reagent and peptides |
| 03/01/2000 | EP0982317A1 Bivalent inhibitors of the proteasome |
| 03/01/2000 | EP0981642A1 Kappa b kinase, subunits thereof, and methods of using same |
| 03/01/2000 | EP0981542A1 20(s) camptothecin glycoconjugates |
| 03/01/2000 | EP0981539A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
| 03/01/2000 | EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/01/2000 | EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions |
| 03/01/2000 | EP0981358A1 Dolastatin-15 derivatives in combination with taxanes |
| 03/01/2000 | EP0770091B1 Compounds for reversing drug resistance |
| 03/01/2000 | EP0618926B1 New peptide derivatives |
| 03/01/2000 | CN1246059A Polymers |
| 03/01/2000 | CN1245812A Cinnamic acid derivative |
| 02/29/2000 | US6031112 Process for the production of alkoxycarbonyl-dipeptides intermediates in the synthesis of the lisinopril |
| 02/29/2000 | US6030972 2- or 5-aminomethyl,2- or 5-cyanopyrimidines as intermediates of anticoagulants in extracorporeal circulation (heart-lung machine, hemodialysis) |
| 02/29/2000 | US6030950 Pharmaceutical therapeutic use of glutathione derivative |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030640 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube |
| 02/29/2000 | US6030619 Molecular mimetics of meningococcal B epitopes |
| 02/24/2000 | WO2000009664A1 Inhibiting apoptosis in plants using a caspase inhibitor |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009548A1 Chemical synthesis of exochelins |
| 02/24/2000 | WO2000009546A1 Process for the preparation of regular glycopeptides |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders |
| 02/24/2000 | CA2339184A1 Chemical synthesis of exochelins |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/23/2000 | EP0980373A1 Reverse-turn mimetics and methods relating thereto |
| 02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245400A Sweetener composition improved in taste |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028196 Using inexpensive and environmentally acceptable starting materials reagents and solvents, no chromatographic purification of intermediate spiroindoline sulfonamide to produce the stimulants for releasing somatotropin |
| 02/22/2000 | US6028172 Reactor and method for solid phase peptide synthesis |
| 02/22/2000 | US6028087 Platelet aggregation inhibiting compounds |
| 02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
| 02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
| 02/22/2000 | CA1340902C Amino acid derivative anticonvulsant |
| 02/17/2000 | WO2000008048A2 Inhibitor of histone deacetylase |
| 02/17/2000 | WO2000008047A1 Depsipeptide derivatives bearing piperazinone rings |
| 02/17/2000 | WO2000008046A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 02/17/2000 | WO2000008015A2 Fsh mimetics for the treatment of infertility |
| 02/17/2000 | WO2000007982A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device |
| 02/17/2000 | WO2000007966A1 Transition metal complexes as linkers |
| 02/17/2000 | CA2339638A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 02/17/2000 | CA2339102A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device |
| 02/17/2000 | CA2339018A1 Fsh mimetics for the treatment of infertility |
| 02/16/2000 | EP0979829A2 Cosmetic or dermatologic compositions containing oligopeptides for clearing age spots, e.g. for prevention of skin tanning, in particular when caused by UV-radiations |
| 02/16/2000 | EP0979828A1 A method for the diagnosis of autism |
| 02/16/2000 | EP0979827A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same |
| 02/16/2000 | EP0979245A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof |
| 02/16/2000 | EP0979242A2 Substituted oxadiazole cysteine protease inhibitors |
| 02/16/2000 | EP0979241A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 02/16/2000 | EP0979240A1 Serine protease inhibitors |
| 02/15/2000 | US6025500 Heterogeneous catalytic reductive amination between alanylproline and ethyl-2-oxo-4-phenylbutyrate |
| 02/15/2000 | US6025472 N-substituted glycine derivatives as enzyme inhibitors |
| 02/15/2000 | US6025444 Cinnamic acid derivative |
| 02/15/2000 | US6025328 Antitumor agents |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/10/2000 | WO2000006747A2 Enzymes for biopolymer production |
| 02/10/2000 | WO2000006594A1 Novel thiazolidine derivatives |
| 02/09/2000 | EP0978518A1 Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester by vaporization of droplets of slurry through a layer of cold air |
| 02/09/2000 | EP0977985A1 Method of determining three-dimensional protein structure from primary protein sequence |
| 02/09/2000 | EP0977773A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977772A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977726A1 Process for esterification of amino acids and peptides |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022994 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |